Existing drug alleviates symptoms of a rare genetic syndrome

FHS
May 30, 2024
7:15 pm

A drug approved to treat certain autoimmune diseases and cancers successfully alleviated symptoms of a rare genetic syndrome called autoimmune polyendocrine syndrome type 1 (APS-1).

Ophthalmological method can be used to monitor neurodegeneration in Parkinson’s patients

A study by the University of the Basque Country (UPV/EHU) and Biobizkaia proposes using an available, simple, non-invasive tool to monitor this neurodegeneration.

April 22, 2024

Quick Test Helps Detect Dementia

The 5-Cog assessment tool helped improve dementia-related care in primary care patients. 5-Cog tripled the odds that a patient would receive a dementia-related intervention within

June 8, 2024

Study Assuages Fears of Pancreatic Cancer Risk With GLP-1 Receptor Agonists

Several years after initiating treatment, GLP-1 receptor agonist users didn’t have a pancreatic cancer safety signal, a historical cohort study reported. Compared with basal insulin

January 5, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.